147 related articles for article (PubMed ID: 38484346)
1. A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome.
Altunsoy A; Kemirtlek N; Araz H; Dirik EB; Akıncı E
J Infect Dev Ctries; 2024 Feb; 18(2):188-194. PubMed ID: 38484346
[TBL] [Abstract][Full Text] [Related]
2. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series.
Olbert E; Alhani N; Struhal W
Wien Med Wochenschr; 2024 Feb; 174(1-2):30-34. PubMed ID: 37523107
[TBL] [Abstract][Full Text] [Related]
4. Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
Aktekin EH; Gezer HÖ; Yazıcı N; Erol İ; Erbay A; Sarıalioğlu F
Neuropediatrics; 2024 Feb; 55(1):57-62. PubMed ID: 37019145
[TBL] [Abstract][Full Text] [Related]
5. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
Nelson JL; Blume GM; Bansal SK; Kaufman JR; Woods FR; Zhang X; Kattah JC
J Neuroophthalmol; 2022 Jun; 42(2):251-255. PubMed ID: 34974489
[TBL] [Abstract][Full Text] [Related]
6. Opsoclonus-myoclonus syndrome following influenza a infection.
Morita A; Ishihara M; Kamei S; Ishikawa H
Intern Med; 2012; 51(17):2429-31. PubMed ID: 22975562
[TBL] [Abstract][Full Text] [Related]
7. Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
Urrea-Mendoza E; Okafor K; Ravindran S; Absher J; Chaubal V; Revilla FJ
Tremor Other Hyperkinet Mov (N Y); 2021 Feb; 11():7. PubMed ID: 33614199
[TBL] [Abstract][Full Text] [Related]
8. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.
Finsterer J; Scorza FA
Neuroophthalmology; 2023; 47(1):1-6. PubMed ID: 36798867
[TBL] [Abstract][Full Text] [Related]
10. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?
Galstyan A; Wilbur C; Selby K; Hukin J
Pediatr Neurol; 2017 Jul; 72():65-69. PubMed ID: 28479124
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and prognostic analysis of opsoclonus-myoclonus-ataxia syndrome in children].
Zhou J; Zhuo XW; Jin M; Duan C; Zhang WH; Ren CH; Gong S; Tian XJ; Ding CH; Ren XT; Li JW
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):256-261. PubMed ID: 38378288
[No Abstract] [Full Text] [Related]
12. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.
Rossor T; Yeh EA; Khakoo Y; Angelini P; Hemingway C; Irani SR; Schleiermacher G; Santosh P; Lotze T; Dale RC; Deiva K; Hero B; Klein A; de Alarcon P; Gorman MP; Mitchell WG; Lim M;
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260471
[TBL] [Abstract][Full Text] [Related]
14. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
Patel A; Fischer C; Lin YC; Basu EM; Kushner BH; De Braganca K; Khakoo Y
Pediatr Blood Cancer; 2020 Aug; 67(8):e28319. PubMed ID: 32543116
[TBL] [Abstract][Full Text] [Related]
15. Adult-onset opsoclonus-myoclonus syndrome due to West Nile Virus treated with intravenous immunoglobulin.
Hébert J; Armstrong D; Daneman N; Jain JD; Perry J
J Neurovirol; 2017 Feb; 23(1):158-159. PubMed ID: 27473195
[TBL] [Abstract][Full Text] [Related]
16. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
[TBL] [Abstract][Full Text] [Related]
17. Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
Deniz A; Alikılıç D; Öztürk M; Karaca Ö; Güngör M; Kara B
J AAPOS; 2023 Apr; 27(2):110-112. PubMed ID: 36736453
[TBL] [Abstract][Full Text] [Related]
18. Opsoclonus myoclonus ataxia syndrome following COVID-19 infection.
Ismail II; Kamel WA; Kilany A
Acta Neurol Belg; 2023 Apr; 123(2):715-716. PubMed ID: 35836090
[No Abstract] [Full Text] [Related]
19. A Rare Case of Opsoclonus Myoclonus Ataxia Syndrome Post Viral Illness.
Shah NS; Pathak J; Shah PC; Bharmal UF; Ansari MI
Cureus; 2023 Jun; 15(6):e40396. PubMed ID: 37456490
[TBL] [Abstract][Full Text] [Related]
20. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Emamikhah M; Babadi M; Mehrabani M; Jalili M; Pouranian M; Daraie P; Mohaghegh F; Aghavali S; Zaribafian M; Rohani M
J Neurovirol; 2021 Feb; 27(1):26-34. PubMed ID: 33492608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
